Lars Stenbygaard
Impact in
- Cancer Research top 5%
- Breast Cancer Treatment Studies
- Cancer, Lipids, and Metabolism
- Oncology top 5%
- Cancer Risks and Factors
- Cancer Diagnosis and Treatment
Papers in
-
- Breast Cancer Treatment Studies 12
- Oncology 13
- Cancer Treatment and Pharmacology 5
- Cancer Diagnosis and Treatment 5
- Co-authors
- Erik Jakobsen (9 shared papers)Maj‐Britt Jensen (5 shared papers)Marianne Ewertz (3 shared papers)Dorte Nielsen (3 shared papers)Søren Cold (6 shared papers)Ulla Brix Tange (1 shared paper)Inger Højris (1 shared paper)K. Gunnarsdóttir (1 shared paper)
In The Last Decade
Lars Stenbygaard
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 66
- Cancer Research 416
- Oncology 498
- Radiation 74
- Pulmonary and Respiratory Medicine 172
- Pathology and Forensic Medicine 60
Countries citing papers authored by Lars Stenbygaard
This map shows the geographic impact of Lars Stenbygaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Stenbygaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Stenbygaard more than expected).
Fields of papers citing papers by Lars Stenbygaard
This network shows the impact of papers produced by Lars Stenbygaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Stenbygaard. The network helps show where Lars Stenbygaard may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Stenbygaard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 450 | |
| 2 | 2020 | 147 | |
| 3 | 2013 | 147 | |
| 4 | 1993 | 70 | |
| 5 | 2022 | 46 | |
| 6 | 2022 | 44 | |
| 7 | 1999 | 43 | |
| 8 | 1999 | 26 | |
| 9 | 2011 | 25 | |
| 10 | 2008 | 23 | |
| 11 | 1997 | 21 | |
| 12 | 2011 | 20 | |
| 13 | 1995 | 8 | |
| 14 | 2019 | 6 | |
| 15 | 1993 | 5 | |
| 16 | 1997 | 5 | |
| 17 | 2024 | 4 | |
| 18 | 2017 | 4 | |
| 19 | 2020 | 3 | |
| 20 | The DBCG RT NATURAL trial: Accelerated partial breast irradiation versus no irradiation for early stage breast cancer, a clinically controlled randomized phase III trial | 2018 | 3 |
About Lars Stenbygaard
Lars Stenbygaard is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (12 papers), Cancer Treatment and Pharmacology (5 papers), Cancer Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Medical Imaging Techniques and Applications (3 papers), Advances in Oncology and Radiotherapy (3 papers), Medical Imaging and Pathology Studies (3 papers) and Advanced Radiotherapy Techniques (2 papers). The work is most often cited by research in Cancer Research (416 citations), Oncology (498 citations), Radiation (74 citations), Pulmonary and Respiratory Medicine (172 citations) and Pathology and Forensic Medicine (60 citations). Lars Stenbygaard has collaborated with scholars based in Denmark, Germany and Norway. Frequent co-authors include Erik Jakobsen, Maj‐Britt Jensen, Marianne Ewertz, Dorte Nielsen, Søren Cold, Ulla Brix Tange, Inger Højris, K. Gunnarsdóttir, Birgitte Vrou Offersen and Mette Holck Nielsen. Their work appears in journals such as Journal of Clinical Oncology, Acta Oncologica, Radiotherapy and Oncology, Lung Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.